180 related articles for article (PubMed ID: 6529534)
1. Serum protein binding and the role of increased alpha 1-acid glycoprotein in moderately obese male subjects.
Benedek IH; Blouin RA; McNamara PJ
Br J Clin Pharmacol; 1984 Dec; 18(6):941-6. PubMed ID: 6529534
[TBL] [Abstract][Full Text] [Related]
2. Serum alpha 1-acid glycoprotein and the binding of drugs in obesity.
Benedek IH; Fiske WD; Griffen WO; Bell RM; Blouin RA; McNamara PJ
Br J Clin Pharmacol; 1983 Dec; 16(6):751-4. PubMed ID: 6661365
[TBL] [Abstract][Full Text] [Related]
3. Factors affecting serum protein binding of phenytoin, diazepam and propranolol in acute renal diseases.
Tiula E; Haapanen EJ; Neuvonen PJ
Int J Clin Pharmacol Ther Toxicol; 1987 Sep; 25(9):469-75. PubMed ID: 3679617
[TBL] [Abstract][Full Text] [Related]
4. Altered drug-serum protein binding in the genetically obese Zucker rat.
Benedek IH; Blouin RA; McNamara PJ
J Pharm Sci; 1985 Aug; 74(8):837-40. PubMed ID: 4032266
[TBL] [Abstract][Full Text] [Related]
5. Serum protein binding of phenytoin, diazepam and propranolol in chronic renal diseases.
Tiula E; Tallgren LG; Neuvonen PJ
Int J Clin Pharmacol Ther Toxicol; 1987 Oct; 25(10):545-52. PubMed ID: 3429058
[TBL] [Abstract][Full Text] [Related]
6. Influence of smoking on serum protein composition and the protein binding of drugs.
Benedek IH; Blouin RA; McNamara PJ
J Pharm Pharmacol; 1984 Mar; 36(3):214-6. PubMed ID: 6144765
[TBL] [Abstract][Full Text] [Related]
7. The protein binding of phenytoin, propranolol, diazepam, and AL01576 (an aldose reductase inhibitor) in human and rat diabetic serum.
McNamara PJ; Blouin RA; Brazzell RK
Pharm Res; 1988 May; 5(5):261-5. PubMed ID: 3149736
[TBL] [Abstract][Full Text] [Related]
8. Serum protein binding of phenytoin, diazepam and propranolol in age-related decrease in renal function.
Tiula E; Elfving S
Ann Clin Res; 1987; 19(3):163-9. PubMed ID: 3674731
[TBL] [Abstract][Full Text] [Related]
9. Influence of continuous ambulatory peritoneal dialysis on serum alpha 1-acid glycoprotein concentration and drug binding.
Belpaire FM; Van de Velde EJ; Fraeyman NH; Bogaert MG; Lameire N
Eur J Clin Pharmacol; 1988; 35(4):339-43. PubMed ID: 3197741
[TBL] [Abstract][Full Text] [Related]
10. Influence of age on serum protein binding of propranolol.
Bendayan R; Pieper JA; Stewart RB; Caranasos GJ
Eur J Clin Pharmacol; 1984; 26(2):251-4. PubMed ID: 6723765
[TBL] [Abstract][Full Text] [Related]
11. Binding of fosphenytoin, phosphate ester pro drug of phenytoin, to human serum proteins and competitive binding with carbamazepine, diazepam, phenobarbital, phenylbutazone, phenytoin, valproic acid or warfarin.
Lai CM; Moore P; Quon CY
Res Commun Mol Pathol Pharmacol; 1995 Apr; 88(1):51-62. PubMed ID: 7620838
[TBL] [Abstract][Full Text] [Related]
12. Serum protein binding of diazepam and propranolol in the feto-maternal unit from early to late pregnancy.
Krauer B; Nau H; Dayer P; Bischof P; Anner R
Br J Obstet Gynaecol; 1986 Apr; 93(4):322-8. PubMed ID: 3964607
[TBL] [Abstract][Full Text] [Related]
13. Alpha-1-acid glycoprotein concentrations and protein binding of propranolol in Sprague-Dawley and Dark Agouti rat strains treated by phenobarbital.
Chauvelot-Moachon L; Delers F; Poüs C; Engler R; Tallet F; Giroud JP
J Pharmacol Exp Ther; 1988 Mar; 244(3):1103-8. PubMed ID: 3252025
[TBL] [Abstract][Full Text] [Related]
14. Plasma protein binding of catecholamines, prazosin and propranolol in diabetes mellitus.
Trovik TS; Jaeger R; Jorde R; Ingebretsen O; Sager G
Eur J Clin Pharmacol; 1992; 43(3):265-8. PubMed ID: 1425889
[TBL] [Abstract][Full Text] [Related]
15. Altered serum protein binding of carbamazepine in disease states associated with an increased alpha 1-acid glycoprotein concentration.
Baruzzi A; Contin M; Perucca E; Albani F; Riva R
Eur J Clin Pharmacol; 1986; 31(1):85-9. PubMed ID: 3780833
[TBL] [Abstract][Full Text] [Related]
16. Effect of total drug concentration on the free fraction in uremic sera.
Tiula E; Neuvonen PJ
Ther Drug Monit; 1986; 8(1):27-31. PubMed ID: 3961893
[TBL] [Abstract][Full Text] [Related]
17. Effects of cancer and its treatments on plasma concentration of alpha 1-acid glycoprotein and propranolol binding.
Abramson FP; Jenkins J; Ostchega Y
Clin Pharmacol Ther; 1982 Nov; 32(5):659-63. PubMed ID: 7128007
[TBL] [Abstract][Full Text] [Related]
18. Variable binding of propranolol in human serum.
Sager G; Nilsen OG; Jacobsen S
Biochem Pharmacol; 1979 Mar; 28(6):905-11. PubMed ID: 454487
[No Abstract] [Full Text] [Related]
19. Methodologic factors influencing plasma binding of alpha-1-acid glycoprotein-bound and albumin-bound drugs.
Morse DS; Abernethy DR; Greenblatt DJ
Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):535-9. PubMed ID: 3934087
[TBL] [Abstract][Full Text] [Related]
20. Stereoselective binding of propranolol in the elderly.
Colangelo P; Chandler M; Blouin R; McNamara P
Br J Clin Pharmacol; 1989 Apr; 27(4):519-22. PubMed ID: 2719906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
